Is Progyny (PGNY) Attractive After Recent Share Price Weakness And DCF Upside?
- If you are wondering whether Progyny’s current share price actually reflects the value of its fertility benefits business, you are not alone; this article is built to help you frame that question clearly.
- The stock last closed at US$17.52, with returns of 15.7% decline over 7 days, 26.6% decline over 30 days, 31.9% decline year to date and 18.7% decline over the past year, while the 3 year and 5 year returns sit at 49.8% decline and 60.1% decline respectively.
- These moves have arrived alongside ongoing investor focus on Progyny’s role in employer sponsored fertility and family building benefits, with sentiment influenced by how the market views demand for these services within the broader healthcare benefits space. Recent commentary…
Source link
